Complement Is Activated in the Upper Respiratory Tract during Influenza Virus Infection
- 1 May 1991
- journal article
- clinical trial
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 143 (5_pt_1) , 1062-1066
- https://doi.org/10.1164/ajrccm/143.5_pt_1.1062
Abstract
The purpose of this pilot study was to determine whether complement is activated in the upper respiratory tract during experimental influenza virus infection in human volunteers. Seven subjects were challenged with influenza A/Bethesda/1/85 (H3N2), and four subjects received placebo. C3a and C5a concentrations were measured by radioimmunoassay in nasal lavage fluids before challenge and for 8 days after challenge. A significant increase (p less than 0.05) in C3a and C5a concentrations was demonstrated in lavage fluids from subjects who developed influenza illness as compared with uninfected control subjects and infected subjects who remained asymptomatic. Maximal levels of C3a and C5a were detected during the recovery phase of illness. These results suggest that complement is activated in the airway in response to influenza illness.Keywords
This publication has 6 references indexed in Scilit:
- Release of leukotriene C4 in respiratory tract during acute viral infectionThe Journal of Pediatrics, 1988
- Kinins are Generated During Experimental Rhinovirus ColdsThe Journal of Infectious Diseases, 1988
- Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement.Journal of Clinical Investigation, 1985
- Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.The Journal of Immunology, 1983
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Pecularities of lesions in viral and mycoplasma infections of the respiratory tractVirchows Archiv, 1972